Adalimumab use in Paediatric Inflammatory Bowel Disease: A single centre real-life experience

被引：0
|
作者：
El-Lababidi, N. [1 ,2 ]
Fruhauf, P. [2 ]
机构：
[1] General Univ Hosp Prague, Dept Paediat & Inherited Metab Disorders, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Dept Paediat & Inherited Metab Disorders, Prague, Czech Republic
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P596
引用
收藏
页码：I531 / I532
页数：2
相关论文
共 50 条
  • [11] Mucosal healing is achieved in most of the inflammatory bowel disease patients in clinical remission with vedolizumab: a real-life single-centre experience
    Calvo Moya, M. I.
    Omella Usieto, I.
    Vera Mendoza, M. I.
    Matallana Royo, V.
    Gonzalez Partida, I.
    Manso Manrique, M.
    Menchen Viso, B.
    Tellez de Meneses, R. De Lucas
    Gonzalez Rodriguez, M.
    Bella del Castillo, P.
    Gonzalez Lama, Y.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S355 - S355
  • [12] The use of sirolimus for refractory inflammatory bowel disease: A single centre experience
    Mutalib, M.
    Blackstock, S.
    Chadokufa, S.
    Huggett, B.
    Shah, N.
    Elawad, M.
    Kiparissi, F.
    Lindley, K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S195 - S195
  • [13] Use of adalimumab biosimilar ABP 501 in Crohn's disease: A real-life experience
    Ribaldone, D. G.
    Vernero, M.
    Pellicano, R.
    Morino, M.
    Saracco, G. M.
    Astegiano, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S510 - S511
  • [14] Paediatric Integrase Inhibitor Use in a Real-Life Setting: A Single-Centre Cohort Experience 2009-2018
    Abo, Yara-Natalie
    Refsum, Erika
    Mackie, Nicola
    Lyall, Hermione
    Tudor-Williams, Gareth
    Foster, Caroline
    CLINICAL DRUG INVESTIGATION, 2019, 39 (06) : 585 - 590
  • [15] Crohn's Disease Exclusion Diet: A single centre real-life experience
    Lababidi, N. E.
    Pavel, F.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 881 - 882
  • [16] Real-world experience of subcutaneous infliximab use in children with inflammatory bowel disease (IBD) at a tertiary paediatric centre
    Eldredge, J.
    Kaur, R.
    Tano, M.
    Chidgey, T.
    Singh, N.
    Chuah, C. W.
    Magoffin, A.
    Thacker, K.
    O'Loughlin, E.
    Dutt, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1832 - i1833
  • [17] Biological Therapy for Paediatric Inflammatory Bowel Disease: The Scottish Nationwide 'Real Life' Experience
    Jamison, A.
    Basheer, N.
    Wilson, M. L.
    Mahdi, G.
    Goudie, D.
    Russell, R. K.
    Wilson, D. C.
    SCOTTISH MEDICAL JOURNAL, 2009, 54 (04) : 53 - 53
  • [18] Influence of disease location on vedolizumab efficacy in inflammatory bowel disease: a real-life multicentre experience
    Pestour, S.
    Nancey, S.
    Charlois, A. L.
    Bonaz, B.
    Flourie, B.
    Boschetti, G.
    Mathieu, N.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S65 - S66
  • [19] Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)
    Sider, S.
    Cococcioni, L.
    ElZein, A.
    Chadokufa, S.
    Buckingham, R.
    Shah, N.
    Ocholi, A.
    Borrelli, O.
    Kiparissi, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S566 - S566
  • [20] REAL-LIFE PROSPECTIVE EXPERIENCE WITH ADALIMUMAB IN INDUCING REMISSION IN ULCERATIVE COLITIS IN PRIMARY INFLAMMATORY BOWEL DISEASES CENTRES
    Tursi, A.
    Allegretta, L.
    Della Valle, N.
    Elisei, W.
    Forti, G.
    Faggiani, R.
    Lorenzetti, R.
    Mocci, G.
    Penna, A.
    Pranzo, G.
    Paiano, P.
    Ricciardelli, C.
    Zampaletta, C.
    Picchio, M.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E210 - E211
12345